115 related articles for article (PubMed ID: 9179261)
21. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.
Têtu B; Brisson J; Côté C; Brisson S; Potvin D; Roberge N
Int J Cancer; 1993 Sep; 55(3):429-35. PubMed ID: 8397164
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Ishikawa S; Takenaka K; Yanagihara K; Miyahara R; Kawano Y; Otake Y; Hasegawa S; Wada H; Tanaka F
Clin Cancer Res; 2004 Oct; 10(19):6579-85. PubMed ID: 15475447
[TBL] [Abstract][Full Text] [Related]
23. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
24. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
25. The potential prognostic value of cathepsin D protein in serous ovarian cancer.
Chai Y; Wu W; Zhou C; Zhou J
Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer.
Ozer E; Mungan MU; Tuna B; Kazimoğlu H; Yörükoğlu K; Kirkali Z
Urology; 1999 Jul; 54(1):50-5. PubMed ID: 10414726
[TBL] [Abstract][Full Text] [Related]
27. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C
Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993
[TBL] [Abstract][Full Text] [Related]
29. Stromal cell cathepsin D expression and long-term survival in breast cancer.
Joensuu H; Toikkanen S; Isola J
Br J Cancer; 1995 Jan; 71(1):155-9. PubMed ID: 7819033
[TBL] [Abstract][Full Text] [Related]
30. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin D expression in skin metastasis of breast cancer.
Inoue H; Kawada A; Takasu H; Maruyama R; Hata Y; Hiruma M; Tajima S; Ishibashi A
J Cutan Pathol; 1998 Aug; 25(7):365-9. PubMed ID: 9765021
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin D and its prognostic value in neuroepithelial brain tumors.
Pigac B; Dmitrović B; Marić S; Masić S
Coll Antropol; 2012 Mar; 36(1):227-33. PubMed ID: 22816225
[TBL] [Abstract][Full Text] [Related]
33. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.
Fernandez-Aguilar S; Noël JC
APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778
[TBL] [Abstract][Full Text] [Related]
34. [Cytosolic cathepsin D levels in squamous carcinomas of the lung].
Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF
Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases.
Moriya Y; Niki T; Yamada T; Matsuno Y; Kondo H; Hirohashi S
Cancer; 2001 Mar; 91(6):1129-41. PubMed ID: 11267958
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer.
Sukoh N; Abe S; Ogura S; Isobe H; Takekawa H; Inoue K; Kawakami Y
Cancer; 1994 Jul; 74(1):46-51. PubMed ID: 8004582
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.
González-Vela MC; Garijo MF; Fernández F; Buelta L; Val-Bernal JF
Histopathology; 1999 Jan; 34(1):35-42. PubMed ID: 9934582
[TBL] [Abstract][Full Text] [Related]
38. Activity and tissue localization of cathepsin D in non small cell lung cancer.
Chyczewski L; Płoński A; Chyczewska E; Furman M; Ostrowska H; Nikliński J; Kozłowski M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539
[TBL] [Abstract][Full Text] [Related]
39. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.
Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W
Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
